Ladarixin
Product Specifications
CAS Number
849776-05-2
Synonyms
DF 2156A free base
Target
CXCR
Applications
GPCR & G Protein
Molecular Formula
C11H12F3NO6S2
Additionnal Information
Ladarixin (DF 2156A free base) is a small molecule, orally available, allosteric and non-competitive antagonist of dual CXCR1 and CXCR2. It is able to reduce the acute and chronic neutrophilic influx, and can be used in research of Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD, cutaneous and uveal melanoma conditions.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OA07324-01 1 mg
2-Acetamido-1,6-di-O-benzyl-3-O- (2,3,4-tri-O-benzyl-a-L-fucopyranosyl) -4-O-[2-O- (2,3,4-tri-O-benzyl-a-L-fucopyranosyl) -3,4,6-tri-O-b enzyl-b-D-galactopyranosyl]-2-deoxy-D-glucopyranoside
Sign In for Pricing
View Details OA07324-02 2 mg
2-Acetamido-1,6-di-O-benzyl-3-O- (2,3,4-tri-O-benzyl-a-L-fucopyranosyl) -4-O-[2-O- (2,3,4-tri-O-benzyl-a-L-fucopyranosyl) -3,4,6-tri-O-b enzyl-b-D-galactopyranosyl]-2-deoxy-D-glucopyranoside
Sign In for Pricing
View Details OA07324-03 5 mg
2-Acetamido-1,6-di-O-benzyl-3-O- (2,3,4-tri-O-benzyl-a-L-fucopyranosyl) -4-O-[2-O- (2,3,4-tri-O-benzyl-a-L-fucopyranosyl) -3,4,6-tri-O-b enzyl-b-D-galactopyranosyl]-2-deoxy-D-glucopyranoside
Sign In for Pricing
View Details orb3009561-01 20 µg
Recombinant Human T cell receptor alpha variable 21 (TVA21)
Sign In for Pricing
View Details